Kidney Transplant; ComplicationsNCT05715580
Impact of Nursing Intervention in Kidney Transplant Recipients Adherence
A study testing Nursing information with a Protocol and Usual clinical practice in people with Kidney Transplant; Complications, run by Hospital San Carlos, Madrid at 5 sites in Spain.
Trial summary
The goal of this clinical trial is to analyse the impact of an informative nursing intervention in the adherence to drug treatment and a healthy lifestyle in kidney transplant patients and the effect of poor adherence on clinical predictors of poor kidney function. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Kidney Transplant; Complications
- What is being tested?
- Nursing information with a Protocol and Usual clinical practice
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 204 participants
- Where
- 5 sitesSpain
- Study dates
- 15 Apr 2023to Dec 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Have a kidney transplant
- Agree to participate
Who cannot join
- If the habitual residence is not in Madrid
- Those whose review frequency in the Kidney Transplant Consultation is planned for more than 6 months
- Pre-transplant hyperimmunized patients (Presence of preformed antibodies >75%)
- Those who are not qualified to give their informed consent
- Those who do not read or understand the document well Spanish
Trial locations and contacts
5 sites in 1 country.
5 sites in 1 country
Spain5 sites
Hospital General Universitario Gregorio Marañón
Madrid, Madrid, 28007
Fernando González García, Nurse, 915868000, fgonzalezgarcia@salud.madrid.org
Hospital Universitario Ramón y Cajal
Madrid, Madrid, 28034
Virginia Hidalgo González, Nurse, 913368000, virgy_hg@hotmail.com
Hospital Clínico San Carlos
Madrid, Madrid, 28040
Araceli Faraldo Cabana, Nurse, 913303000 ext. 3156, a_faraldo@hotmail.com
Hospital Universitario 12 de Octubre
Madrid, Madrid, 28041
Enriqueta Isabel Nuño Santana, Nurse, 913908000, enriquetaisabel.nuno@salud.madrid.org
Hospital Universitario La Paz
Madrid, Madrid, 28046
María José Santana Valeros, Nurse, 917277000, mjose.santana@salud.madrid.org
About this study
Official title: A Clinical Trial to Assess the Impact of Nursing Intervention in the Adherence to Drug Treatment and to a Healthy Lifestyle in Kidney Transplant Patients
The goal of this clinical trial is to analyse the impact of an informative nursing intervention in the adherence to drug treatment and a healthy lifestyle in kidney transplant patients and the effect of poor adherence on clinical predictors of poor kidney function.
The main question[s] it aims to answer are:
- Is it possible improve the drug adherence of kidney recipients with a nursing information intervention?
- Is it possible improve the healthy lifestyle adherence of kidney recipients with a nursing information intervention? Participants will be divided into two groups: Intervention group: in which a health education action will be carried out and Control group in which the usual clinical practice will be maintained.
Read the detailed description
A controlled, multicenter, single-blind clinical trial will be carried out. For this, 3 measurements will be made, a first baseline, prior to the intervention, and another two follow-up six and twelve months after the first. Patients will be divided into two groups:
- Intervention group: in which a health education action will be carried out through the delivery of an Information Guide for adults with a kidney transplant and the regulated explanation of each of the items it contains. It will be carried out by the nurse from the Kidney Transplant Clinic responsible for follow-up, who in turn will receive an online training session, prior to the start of recruitment, on what information to provide and how to provide it.
- Control group in which the usual clinical practice will be maintained, which consists of providing the information in the immediate post-transplant period and resolving any doubts that the patient may have during the follow-up period.
The study will be carried out in the five existing Nursing Consultations, specific to Renal Transplantation, belonging to as many hospitals of the Public Health Network of the Community of Madrid.
Study population Those patients with a functioning kidney transplant, under follow-up by one of the nursing consultations where the research will be carried out, over 18 years of age who agree to participate and sign the informed consent will be selected. Patients monitored by the clinic whose habitual residence is in an Autonomous Community other than Madrid will be excluded, those in which the frequency of revision in the Renal Transplant Clinic is scheduled for more than 6 months, as well as those hyperimmunized pre-transplant patients (Presence of preformed antibodies >75%) and those who are not trained to give their informed consent and those who do not read or understand Spanish well.
Calculation of sample size and sampling. In order to achieve the main objective of evaluating the efficacy of an informative intervention by the nurse in the adherence of the kidney transplant recipient and according to the calculations made, starting from an adherence based on the bibliography, of 50% in both arms of the study, and to detect a change of at least 20% in it, a sample of 93 patients per arm will be needed, plus an estimated 10% of losses, which results in 102 patients per arm, 204 in total.
Given the high volume of subjects seen in each of the kidney transplant consultations throughout the year, it is expected to recruit the sample in the estimated period. For example, at the Hospital Clínico San Carlos and Hospital La Paz there are more than 600 patients under follow-up, while at Hospital Ramón y Cajal there are more than 800, and at Hospital 12 de Octubre more than 2,000, with an average of daily, in each one of the consultations, of minimum 20 visits.
An intermediate analysis will be carried out, when a third of the sample has undergone the assessment of the 6 months after the intervention, and based on the result obtained, the necessary sample will be recalculated.
This calculation has been estimated with the GRANMO v.7.12 program. Randomization To carry out the randomization, firstly, it will be stratified by hospital center. Once the stratification has been carried out, the random assignment will proceed by means of a simple randomization with a sequence of random numbers generated by means of the Excel® computer program, which uses the Mersenne Twister algorithm. To do this, a sequenced list will be generated that will contain even and other odd numbers in equal amounts, assigning the patients whose random number is even to the control group and to the intervention group if the number is odd. In this way, any person who attends the consultation, meets all the inclusion requirements and none of the exclusion requirements, will have the same probability of being assigned to one or the other group. The nurse from the Renal Transplant Clinic will be in charge and responsible for carrying out the assignment process, using the random sequence provided by the principal investigator in a sealed envelope, in such a way that the nurse in charge of the assignment will not know it until the same moment of carrying out the intervention or not.
Data collection The Renal Transplant Clinic nurses will select the subjects by consecutive sampling, from a given date, until completing the sample assigned to each of the five Nursing Clinics. This allocation will be carried out based on the number of patients under follow-up in each consultation.
Once the subjects have been selected by consecutive sampling from a given date, the nurse from the Renal Transplant Clinic, in charge of conducting the interview, will explain the objectives of the study to the study subject and obtain their written informed consent.
Subsequently, membership in the control group or intervention group will be randomized.
For biomedical data, an exhaustive review of the patient's Clinical History will be carried out. These data will be collected by an independent investigator, blind to the intervention group to which the patient belongs (control group or intervention group), both in the baseline assessment and in the measurements at 6 and 12 months.
- Conditions
- Kidney Transplant; Complications
- Being tested
- Nursing information with a Protocol, Usual clinical practice
- Keywords
- Kidney transplantation, Treatment adherence and compliance, Clinical trial, Health Education
- Medical subject headings
- Treatment Adherence and Compliance, Health Education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Nursing information with a ProtocolOther
The nursing intervention will consist of providing information to the patient with a kidney transplant.
To do this, a Committee of experts, made up of the 6 nurses from the kidney transplant Consultations of the Community of Madrid (Spain), will carry out an Information Protocol for adults with a kidney transplant, which will cover the healthy lifestyle habits described by the bibliography
Usual clinical practiceOther
Nursing information following the usual clinical practice
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Active comparator | The nursing intervention will consist of providing information to the patient with a KT about the importance of following the prescribed therapeutic regimen, at the same time the information they may have about healthy lifestyle habits will be expanded, with special emphasis on those areas in which there has been detected, through the administered questionnaires, a lack of adherence. Receives: Other: Nursing information with a Protocol |
| Control group | Placebo comparator | The control group will be informed of the same aspects following the usual clinical practice, which consists of providing the information in the immediate post-transplant period, and resolving any doubts that the patient may have during the subsequent time. Receives: Other: Usual clinical practice |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in Adherence to prescribed medication
Measured by the Morisky-Green test
Measured: Basal, 6 and 12 months after the basal
Secondary outcomes (6)
Changes in Adherence to physical exercise
Measured by the Brief Physical Activity Assessment tool
Measured: Basal, 6 and 12 months after the basal
Changes in Adherence to healthy food
Measured by a questionnaire created for this study
Measured: Basal, 6 and 12 months after the basal
Changes in alcohol consumption
Measured by CAGE test
Measured: Basal, 6 and 12 months after the basal
Changes in tobacco consumption
Measured by IPA
Measured: Basal, 6 and 12 months after the basal
Changes in Presence of emotional well-being
Measured by the WHO-5 test
Measured: Basal, 6 and 12 months after the basal
Changes in Security / Prevention of unintentional injuries
Measured by a questionnaire created for this study
Measured: Basal, 6 and 12 months after the basal
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2023
- Study start15 Apr 2023 (estimated)
- Primary completionDec 2024 (estimated)
- Study completionDec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (50)Papers the sponsor has linked to this study.
- Other trials for Kidney Transplant; ComplicationsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 204 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hospital San Carlos, Madrid
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Araceli Faraldo Cabana, Hospital San Carlos, Madrid
- Investigators
- Araceli Faraldo Cabana, Nurse, Principal investigator, Hospital San Carlos, Madrid
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05715580
- Sponsor's protocol ID
- 22/325-EC_X
- Status last verified
- Mar 2023
- First submitted
- 16 Jan 2023
- Last updated
- 8 Mar 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Memoria de Actividad de donación y trasplante renal España 2020 [Internet]. 2020. Available from: http://www.ont.es/infesp/Memorias/ACTIVIDAD DE DONACIÓN Y TRASPLANTE RENAL ESPAÑA 2020.pdf
World Health Organization. Adherence to long-term therapies : evidence for action / [edited by Eduardo Sabaté] [Internet]. Geneva PP - Geneva: World Health Organization; Available from: https://apps.who.int/iris/handle/10665/42682
Lopez V, Hernandez D, Gonzales M. Resultados globales del trasplante renal | Nefrología al día. Nefrol al Dia [Internet]. 2021;3:1-12. Available from: https://www.nefrologiaaldia.org/es-articulo-resultados-globales-del-trasplante-renal-58
Foundation NK. Nutrition and Transplant [Internet]. 2022 [cited 2022 Jan 18]. Available from: https://www.kidney.org/nutrition/transplant
Estrategia de promoción de la salud y prevención en el SNS [Internet]. Madrid; Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/Estrategia/docs/EstrategiaPromocionSaludyPrevencionSNS.pdf
El said SH, El Hoseiny S, El Raouf A, El Dahashan KF, Gad R, El Kader A. Lifestyle Modification among Post Renal Transplant Recipient. IOSR J Nurs Heal Sci. 2017;06(03):92-113
Pagès-Puigdemont N, Valverde-Merino MI. Métodos para medir la adherencia terapeútica. Ars Pharm. 2018;59(3):163-72.
CKD Group. Kidney Disease: Improving Global Outcomes (KDIGO). Kidney int. 2012;3(2013):1-150
Tan X, Patel I, Chang J. Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Sacle (MMAS-8). Inov Pharm. 2014;5(3):165.
Staehr Johansen K. The use of well-being measures in primary health care - the DepCare project. 1998.
World Health Organisation. Wellbeing Measures in Primary Health Care/ The Depcare Project. Rep a WHO Meet [Internet]. 1998;45. Available from: http://www.euro.who.int/__data/assets/pdf_file/0016/130750/E60246.pdf
Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001 Jun;12(6):1293-1296. doi: 10.1681/ASN.V1261293.
PubMed 11373354Thiruchelvam PT, Willicombe M, Hakim N, Taube D, Papalois V. Renal transplantation. BMJ. 2011 Nov 14;343:d7300. doi: 10.1136/bmj.d7300. No abstract available.
PubMed 22084316Senanayake S, Graves N, Healy H, Baboolal K, Barnett A, Sypek MP, Kularatna S. Donor Kidney Quality and Transplant Outcome: An Economic Evaluation of Contemporary Practice. Value Health. 2020 Dec;23(12):1561-1569. doi: 10.1016/j.jval.2020.07.007. Epub 2020 Sep 15.
PubMed 33248511Pascazio L, Nardone IB, Clarici A, Enzmann G, Grignetti M, Panzetta GO, Vecchiet C. Anxiety, depression and emotional profile in renal transplant recipients and healthy subjects: a comparative study. Transplant Proc. 2010 Nov;42(9):3586-90. doi: 10.1016/j.transproceed.2010.08.056.
PubMed 21094820
Study at a glance
From the registry record, last updated by the sponsor on 8 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Clinical Trial to Assess the Impact of Nursing Intervention in the Adherence to Drug Treatment and to a Healthy Lifestyle in Kidney Transplant Patients
- ClinicalTrials.gov ID
- NCT05715580
- Acronym / sponsor ID
- 22/325-EC_X
- Conditions
- Kidney Transplant; Complications
- Keywords
- Kidney transplantation, Treatment adherence and compliance, Clinical trial, Health Education
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 204 participants (estimated)
- Lead sponsor
- Hospital San Carlos, MadridUniversity, hospital or other
- Study start
- 15 Apr 2023 (estimated)
- Primary completion
- Dec 2024 (estimated)
- Study completion
- Dec 2024 (estimated)
- First posted
- 8 Feb 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to analyse the impact of an informative nursing intervention in the adherence to drug treatment and a healthy lifestyle in kidney transplant patients and the effect of poor adherence on clinical predictors of poor kidney function.
The main question[s] it aims to answer are:
- Is it possible improve the drug adherence of kidney recipients with a nursing information intervention?
- Is it possible improve the healthy lifestyle adherence of kidney recipients with a nursing information intervention? Participants will be divided into two groups: Intervention group: in which a health education action will be carried out and Control group in which the usual clinical practice will be maintained.
Detailed description
A controlled, multicenter, single-blind clinical trial will be carried out. For this, 3 measurements will be made, a first baseline, prior to the intervention, and another two follow-up six and twelve months after the first. Patients will be divided into two groups:
- Intervention group: in which a health education action will be carried out through the delivery of an Information Guide for adults with a kidney transplant and the regulated explanation of each of the items it contains. It will be carried out by the nurse from the Kidney Transplant Clinic responsible for follow-up, who in turn will receive an online training session, prior to the start of recruitment, on what information to provide and how to provide it.
- Control group in which the usual clinical practice will be maintained, which consists of providing the information in the immediate post-transplant period and resolving any doubts that the patient may have during the follow-up period.
The study will be carried out in the five existing Nursing Consultations, specific to Renal Transplantation, belonging to as many hospitals of the Public Health Network of the Community of Madrid.
Study population Those patients with a functioning kidney transplant, under follow-up by one of the nursing consultations where the research will be carried out, over 18 years of age who agree to participate and sign the informed consent will be selected. Patients monitored by the clinic whose habitual residence is in an Autonomous Community other than Madrid will be excluded, those in which the frequency of revision in the Renal Transplant Clinic is scheduled for more than 6 months, as well as those hyperimmunized pre-transplant patients (Presence of preformed antibodies >75%) and those who are not trained to give their informed consent and those who do not read or understand Spanish well.
Calculation of sample size and sampling. In order to achieve the main objective of evaluating the efficacy of an informative intervention by the nurse in the adherence of the kidney transplant recipient and according to the calculations made, starting from an adherence based on the bibliography, of 50% in both arms of the study, and to detect a change of at least 20% in it, a sample of 93 patients per arm will be needed, plus an estimated 10% of losses, which results in 102 patients per arm, 204 in total.
Given the high volume of subjects seen in each of the kidney transplant consultations throughout the year, it is expected to recruit the sample in the estimated period. For example, at the Hospital Clínico San Carlos and Hospital La Paz there are more than 600 patients under follow-up, while at Hospital Ramón y Cajal there are more than 800, and at Hospital 12 de Octubre more than 2,000, with an average of daily, in each one of the consultations, of minimum 20 visits.
An intermediate analysis will be carried out, when a third of the sample has undergone the assessment of the 6 months after the intervention, and based on the result obtained, the necessary sample will be recalculated.
This calculation has been estimated with the GRANMO v.7.12 program. Randomization To carry out the randomization, firstly, it will be stratified by hospital center. Once the stratification has been carried out, the random assignment will proceed by means of a simple randomization with a sequence of random numbers generated by means of the Excel® computer program, which uses the Mersenne Twister algorithm. To do this, a sequenced list will be generated that will contain even and other odd numbers in equal amounts, assigning the patients whose random number is even to the control group and to the intervention group if the number is odd. In this way, any person who attends the consultation, meets all the inclusion requirements and none of the exclusion requirements, will have the same probability of being assigned to one or the other group. The nurse from the Renal Transplant Clinic will be in charge and responsible for carrying out the assignment process, using the random sequence provided by the principal investigator in a sealed envelope, in such a way that the nurse in charge of the assignment will not know it until the same moment of carrying out the intervention or not.
Data collection The Renal Transplant Clinic nurses will select the subjects by consecutive sampling, from a given date, until completing the sample assigned to each of the five Nursing Clinics. This allocation will be carried out based on the number of patients under follow-up in each consultation.
Once the subjects have been selected by consecutive sampling from a given date, the nurse from the Renal Transplant Clinic, in charge of conducting the interview, will explain the objectives of the study to the study subject and obtain their written informed consent.
Subsequently, membership in the control group or intervention group will be randomized.
For biomedical data, an exhaustive review of the patient's Clinical History will be carried out. These data will be collected by an independent investigator, blind to the intervention group to which the patient belongs (control group or intervention group), both in the baseline assessment and in the measurements at 6 and 12 months.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Active comparator | Other: Nursing information with a ProtocolThe nursing intervention will consist of providing information to the patient with a KT about the importance of following the prescribed therapeutic regimen, at the same time the information they may have about healthy lifestyle habits will be expanded, with special emphasis on those areas in which there has been detected, through the administered questionnaires, a lack of adherence. |
| Control group | Placebo comparator | Other: Usual clinical practiceThe control group will be informed of the same aspects following the usual clinical practice, which consists of providing the information in the immediate post-transplant period, and resolving any doubts that the patient may have during the subsequent time. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Have a kidney transplant
- Agree to participate
Key exclusion criteria (5 listed)
- If the habitual residence is not in Madrid
- Those whose review frequency in the Kidney Transplant Consultation is planned for more than 6 months
- Pre-transplant hyperimmunized patients (Presence of preformed antibodies >75%)
- Those who are not qualified to give their informed consent
- Those who do not read or understand the document well Spanish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Nursing information with a ProtocolThe nursing intervention will consist of providing information to the patient with a kidney transplant. To do this, a Committee of experts, made up of the 6 nurses from the kidney transplant Consultations of the Community of Madrid (Spain), will carry out an Information Protocol for adults with a kidney transplant, which will cover the healthy lifestyle habits described by the bibliography | Other | Intervention group |
| Usual clinical practiceNursing information following the usual clinical practice | Other | Control group |
Primary outcome
Changes in Adherence to prescribed medication
Time frame: Basal, 6 and 12 months after the basal
Measured by the Morisky-Green test
6 secondary outcomes
Changes in Adherence to physical exercise
Time frame: Basal, 6 and 12 months after the basal
Changes in Adherence to healthy food
Time frame: Basal, 6 and 12 months after the basal
Changes in alcohol consumption
Time frame: Basal, 6 and 12 months after the basal
Changes in tobacco consumption
Time frame: Basal, 6 and 12 months after the basal
Changes in Presence of emotional well-being
Time frame: Basal, 6 and 12 months after the basal
Changes in Security / Prevention of unintentional injuries
Time frame: Basal, 6 and 12 months after the basal
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Mar 2023.
- BackgroundMemoria de Actividad de donación y trasplante renal España 2020 [Internet]. 2020. Available from: http://www.ont.es/infesp/Memorias/ACTIVIDAD DE DONACIÓN Y TRASPLANTE RENAL ESPAÑA 2020.pdf
- BackgroundWorld Health Organization. Adherence to long-term therapies : evidence for action / [edited by Eduardo Sabaté] [Internet]. Geneva PP - Geneva: World Health Organization; Available from: https://apps.who.int/iris/handle/10665/42682
- BackgroundLopez V, Hernandez D, Gonzales M. Resultados globales del trasplante renal | Nefrología al día. Nefrol al Dia [Internet]. 2021;3:1-12. Available from: https://www.nefrologiaaldia.org/es-articulo-resultados-globales-del-trasplante-renal-58
- BackgroundFoundation NK. Nutrition and Transplant [Internet]. 2022 [cited 2022 Jan 18]. Available from: https://www.kidney.org/nutrition/transplant
- BackgroundEstrategia de promoción de la salud y prevención en el SNS [Internet]. Madrid; Available from: https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/Estrategia/docs/EstrategiaPromocionSaludyPrevencionSNS.pdf
- BackgroundEl said SH, El Hoseiny S, El Raouf A, El Dahashan KF, Gad R, El Kader A. Lifestyle Modification among Post Renal Transplant Recipient. IOSR J Nurs Heal Sci. 2017;06(03):92-113
- BackgroundPagès-Puigdemont N, Valverde-Merino MI. Métodos para medir la adherencia terapeútica. Ars Pharm. 2018;59(3):163-72.
- BackgroundCKD Group. Kidney Disease: Improving Global Outcomes (KDIGO). Kidney int. 2012;3(2013):1-150
- BackgroundTan X, Patel I, Chang J. Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Sacle (MMAS-8). Inov Pharm. 2014;5(3):165.
- BackgroundStaehr Johansen K. The use of well-being measures in primary health care - the DepCare project. 1998.
- BackgroundWorld Health Organisation. Wellbeing Measures in Primary Health Care/ The Depcare Project. Rep a WHO Meet [Internet]. 1998;45. Available from: http://www.euro.who.int/__data/assets/pdf_file/0016/130750/E60246.pdf
- Results publication: PubMed 11373354Meier-Kriesche HU, Ojo AO, Port FK, Arndorfer JA, Cibrik DM, Kaplan B. Survival improvement among patients with end-stage renal disease: trends over time for transplant recipients and wait-listed patients. J Am Soc Nephrol. 2001 Jun;12(6):1293-1296. doi: 10.1681/ASN.V1261293.
- Individual participant dataSharing planned: No
Related trials for Kidney Transplant; Complications
Not yet recruiting
Hypothermic Kidney Machine Perfusion With Omnisol
End Stage Renal Disease (ESRD), Kidney Transplant
RecruitingObservational study
Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation
Cardiovascular Diseases, Kidney Transplant; Complications
Not yet recruitingObservational study
Assessment of Perceived Stress in an Observational Study Evaluating a Biopsy-sparing Surveillance Strategy in Kidney Transplant Recipients With Blood and Urinary Biomarkers Predictive of the Absence of Rejection
Renal Transplantation; Complication, Renal Transplant
Not yet recruiting
MYTP01 for Immune-Mediated Diseases
IgA Nephropathy, Kidney Transplant Recipients
RecruitingPhase 1/2
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Autoimmune Disorders, Systemic Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Araceli Faraldo Cabana, Nurse principal investigator
Hospital San Carlos, Madrid
5 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Nursing information with a Protocol and Usual clinical practice in people with Kidney Transplant; Complications, run by Hospital San Carlos, Madrid at 5 sites in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 5 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Araceli Faraldo Cabana, Nurse (+34913303000 ext. 3156, a_faraldo@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in Adherence to prescribed medication (time frame: Basal, 6 and 12 months after the basal). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05715580, which also lists 50 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2023.